CFTR and cystic fibrosis: On the other hand, a study by Gentzsch and colleagues highlighted that the infectious/inflammatory milieu of CF airways can enhance VX-809-mediated rescue of F508del-CFTR, demonstrating the existence of a dose–response relationship between airway inflammation and efficacy of CFTR modulators in vitro [114].